Molecular Changes Associated With Teprotumumab Treatment in Thyroid Eye Disease @checkrare
Molecular Changes Associated With Teprotumumab Treatment in Thyroid Eye Disease  @checkrare
Uploaded November 2026 | Updated November 2026, 5 days ago
Sarah Cheng, MD, PhD, a clinical oculoplastic fellow at the University of California, San Diego, discusses findings from an exploratory study examining the biological changes in orbital tissue associated with Tepezza  (teprotumumab-trbw) treatment. The findings were presented at the 2026 American Academy of Ophthalmology (AAO) Annual Meeting in New Orleans, Louisiana.



Rare Discussions is produced by CheckRare, the leading multimedia platform dedicated to advancing education, awareness, and innovation across the rare disease community.

Explore additional physician interviews, podcasts, CME activities, and rare disease resources at CheckRare.com.

Subscribe to the CheckRare Podcast Network for expert conversations, weekly news, accredited education, and the latest advances across the rare disease community.

Part of the CheckRare Podcast Network: Trusted conversations, news, education, and expert insights across the rare disease community.
Molecular Changes Associated With Teprotumumab Treatment in Thyroid Eye DiseaseInvestigating Results From the MAVORIC Trial in Patients With CTCLMiv-cel Shows Durable Results in Stiff Person Syndrome and Myasthenia GravisUCB Study Highlights the Burden of Ocular Myasthenia GravisGambling on Clinical TrialsMolecular Changes Associated With Teprotumumab Treatment in Thyroid Eye DiseaseMiv-cel Shows Durable Results in Stiff Person Syndrome and Myasthenia GravisNarcolepsy Awareness MonthFirst-Line Therapy Approved for Rare Lung Cancer  Safety and Efficacy of Kygevvi in Thymidine Kinase 2 DeficiencyPredicting Treatment Response Outcomes With Proteomic and Machine Learning Analyses in MGDiagnostic Delay in Endocrine Disorders
CheckRare |

Molecular Changes Associated With Teprotumumab Treatment in Thyroid Eye Disease

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER